UCP1 and metabolic dysfunction-associated steatotic liver disease: Improve hepatic steatosis and corrected the BCAA disorder in NAFLD mice, and the related mechanisms regulated the AMPK/SIRT1/UCP-1 pathway and promoted WAT browning